DiscoverIPO

Apnimed, Inc.

expected
Jul 31, 2026
status
Filed with SEC
proposed ticker
APMD
Industry
Pharmaceutical Preparations
Headquarters
United States
Incorporated in
DE
Price range
$16.00
Offer size
$192M

Overview

Business overview

Apnimed, Inc. is a late-stage clinical pharmaceutical company incorporated in June 2017. The company focuses on developing its sole clinical product candidate, Oxnimbi, which has completed Phase 3 clinical trials. It is based in Cambridge, Massachusetts, and qualifies as an 'emerging growth company' under the JOBS Act, allowing it to have reduced reporting obligations.

Revenue model

Not disclosed in the provided filing text.

Risk factors

  • Significant operating losses incurred since inception and expected to continue for the foreseeable future.
  • Dependent on the success of Oxnimbi for business viability and profitability.
  • Need for substantial additional funding to finance operations.
  • Substantial doubt regarding ability to continue as a going concern.
  • Potential side effects and regulatory approval challenges for Oxnimbi and future candidates.
  • Competition with established companies and potential challenges in market penetration.
  • Risks associated with reliance on third parties for clinical trials.
  • Need to protect intellectual property and compliance with license obligations.
  • Dependence on retaining key executives and personnel.

Use of proceeds

Not disclosed in the provided filing text.

This summary is generated automatically from the company's own filing and may contain errors or omissions. It is a reading aid, not a substitute for the filing itself, and it is not advice.

IPO details

The expected date is Jul 31, 2026. Shares are expected to be offered at $16.00, for a total offer size of $192M. The proposed ticker is APMD. Apnimed, Inc. is headquartered in United States and incorporated in DE. It is classified under Pharmaceutical Preparations.

Apnimed, Inc. has filed 2 times, starting with a S1/A on Jul 27, 2026.

Frequently asked questions

When is Apnimed, Inc. expected to go public?

Apnimed, Inc. is expected to list on Jul 31, 2026.

How much is Apnimed, Inc. raising in its IPO?

Apnimed, Inc.'s offering is expected to raise $192M.

What is Apnimed, Inc.'s ticker symbol?

Apnimed, Inc.'s proposed ticker is APMD.

Where this data comes from

Nasdaq's published calendar of upcoming and priced offerings. Retrieved Jul 31, 2026.

View the original filing on Nasdaq IPO Calendar →

All filings for this company

Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public filings and exchange calendars, may be incomplete or out of date, and should be verified against the original source before you act on them.

We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy